SCHEMBL3207092

SCHEMBL3207092

COc1cc(N(Cc2cnco2)c2cccc(C(=O)OC(C)(C)C)c2)ccc1OC(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
GAA P10253 1/20 0.39
AAK1 Q2M2I8 3/20 0.35
GPR119 Q8TDV5 1/20 0.34
SLC7A5 Q01650 1/20 0.33
NPC1 O15118 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDE4B Q07343 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
TSHR P16473 2/20 0.32
CIT O14578 1/20 0.32
GAK O14976 1/20 0.32
PRKX P51817 1/20 0.32
PRKCQ Q04759 1/20 0.32
HASPIN Q8TF76 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3199477 0.93 AAK1 (0.33) POLBGAAAAK1SLC7A5PDE4B
SCHEMBL3193658 0.92 POLB (0.40) POLBGAAAAK1GPR119NPC1
SCHEMBL3130978 0.92 HRH4 (0.36) POLBGAAAAK1SLC7A5PDE4B
SCHEMBL3205424 0.89 AAK1 (0.37) AAK1GPR119SLC7A5PDE4BTSHR
SCHEMBL3203515 0.89 PDE4D (0.40) GPR119PDE4BPDE4APDE4CPDE4D
SCHEMBL3121148 0.89 IMPDH2 (0.39) POLBGAAAAK1NPC1PDE4B
SCHEMBL3215627 0.88 PDE4D (0.43) PDE4BPDE4APDE4CPDE4D
SCHEMBL3129701 0.88 SREBF1 (0.40) POLBAAK1GPR119NPC1L3MBTL1
SCHEMBL3203897 0.88 HDAC6 (0.36) POLBGAAAAK1GPR119PDE4B
SCHEMBL3123133 0.86 SREBF1 (0.37) AAK1GPR119L3MBTL1PDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B POLB 1798/4885GAA 736/4885AAK1 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.